Fig. 3From: Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic modelsSurvival function (solid line) and 95 % CI (dotted lines) of the time to progression (TP) for the whole series (a) and according to the group of risk (b: HiR in red and LR in blue). Vertical lines separate the 9 time intervals considered for this outcomeBack to article page